Lemos, V., de Oliveira, R. M., Naia, L., Szegö, E., et al. (2017). The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes. Human Molecular Genetics, 26(21), 4105 - 4117.

Burisch, J., Vegh, Z., Katsanos, K. H., Christodoulou, D. K., et al. (2017). Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort-An ECCO-EpiCom study. Journal of Crohn's and Colitis, 11(10), 1213 - 1222.

Magro, F., Sousa, P., & Ministro, P. (2014). C-reactive protein in Crohn's disease: How informative is it?. Expert Review of Gastroenterology and Hepatology, 8(4), 393 - 408.

Magro, F., Santos-Antunes, J., Vilas-Boas, F., Rodrigues-Pinto, E., et al. (2014). Crohn's disease outcome in patients under azathioprine: A tertiary referral center experience. Journal of Crohn's and Colitis, 8(7), 617 - 625.

Santos-Antunes, J., Magro, F., & Macedo, G. (2014). Listeria monocytogenes bacteremia and CMV colitis in a patient with Ulcerative Colitis. Journal of Crohn's and Colitis, 8(3), 254 - 255.

Rieder, F., de Bruyn, J. R., Pham, B. T., Katsanos, K., et al. (2014). Results of the 4th Scientific Workshop of the ECCO (Group II): Markers of intestinal fibrosis in inflammatory bowel disease. Journal of Crohn's and Colitis.

Dias, C. C., Rodrigues, P. P., da Costa-Pereira, A., & Magro, F. (2013). Clinical prognostic factors for disabling Crohn's disease: A systematic review and meta-analysis. World Journal of Gastroenterology, 19(24), 3866 - 3871.

Magro, F., Santos-Antunes, J., Albuquerque, A., Vilas-Boas, F., et al. (2013). Epstein-barr virus in inflammatory bowel disease-correlation with different therapeutic regimens. Inflammatory Bowel Diseases, 19(8), 1710 - 1716.

Magro, F., Langner, C., Driessen, A., Ensari, A., et al. (2013). European consensus on the histopathology of inflammatory bowel disease. Journal of Crohn's and Colitis, 7(10), 827 - 851.

Abreu, C., Magro, F., Vilas-Boas, F., Lopes, S., et al. (2013). Listeria infection in patients on anti-TNF treatment: Report of two cases and review of the literature. Journal of Crohn's and Colitis, 7(2), 175 - 182.

Durães, C., Machado, J. C., Portela, F., Rodrigues, S., et al. (2013). Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA Study II). Inflammatory Bowel Diseases, 19(2), 230 - 239.

Cabral, J. M., Soares-Da-Silva, P., & Magro, F. (2013). Short- and long-term regulation of intestinal Na+/H+ exchange activity associated with TLR2 receptor activation is independent of nuclear factor-?b signaling. Journal of Pharmacology and Experimental Therapeutics, 346(3), 453 - 464.

Abreu, C., Magro, F., Santos-Antunes, J., Pilão, A., et al. (2013). Tuberculosis in anti-TNF-? treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control population. Journal of Crohn's and Colitis, 7(10), e486 - e492.

Durães, C., Machado, J. C., Portela, F., Rodrigues, S., et al. (2012). Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II). Inflammatory Bowel Diseases.

Campos, N., Magro, F., Castro, A. R., Cabral, J., et al. (2011). Macrophages from IBD patients exhibit defective tumour necrosis factor-? secretion but otherwise normal or augmented pro-inflammatory responses to infection. Immunobiology, 216(8), 961 - 970.